National Consensus Guidance for the Diagnosis and Management of Adult Patients with Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
Young Nam Kwon(Yonsei University), Ha Young Shin(Yonsei University), Woojun Kim(National Cancer Center), Jin Myoung Seok(Samsung Medical Center), Sa‐Yoon Kang(Jeju National University), Jun‐Soon Kim(Seoul National University Bundang Hospital), Eun‐Jae Lee(Ulsan College), Sung‐Min Kim(Seoul National University Hospital), Ho Jin Kim(National Cancer Center), Seung Woo Kim(Ulsan College), Min Su Park(Yeungnam University College), Ki Hoon Kim(Inje University Sanggye Paik Hospital), Ju‐Hong Min(Samsung Medical Center), Kyong Jin Shin(Inje University Haeundae Paik Hospital), Hyun-June Shin(Yonsei University), Tai‐Seung Nam(Chonnam National University Hospital)
Cited by 1
Related Papers
MOG encephalomyelitis: international recommendations on diagnosis and antibody testing
|Journal of Neuroinflammation|2018|740
Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial
|The Lancet|2019|722
Neuromyelitis optica
|Nature Reviews Disease Primers|2020|464
Development of extensive brain lesions following fingolimod (FTY720) treatment in a patient with neuromyelitis optica spectrum disorder
|Multiple Sclerosis Journal|2011|284
A New Subtype Classification of Ischemic Stroke Based on Treatment and Etiologic Mechanism
|European Neurology|2006|121